Inventor
LAWRENCE KLEIN
Inventor
US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes17%
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C07KPeptides13%
G06QInformation and communication technology [ict] specially adapted for administrative, commercial, financial, managerial or supervisory purposes9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
B60WConjoint control of vehicle sub-units of different type or different function3%
B62DMotor vehicles3%
B60DVehicle connections2%
B60RVehicles, vehicle fittings, or vehicle parts, not otherwise provided for2%
PatentTitleYear
12,442,020Materials and methods for treatment of pain related disorders202512,405,384Systems and methods for determining an articulated trailer angle202512,373,890Methods and systems to quantify and index correlation risk in financial markets and risk management contracts thereon202511,941,645Methods and systems to extract signals from large and imperfect datasets202411,927,676Systems and methods for determining an articulated trailer angle202411,920,148Compositions and methods for gene editing202411,854,083Methods and systems to quantify and index liquidity risk in financial markets and risk management contracts thereon202311,841,971Systems and methods for customer data handling202311,801,313Materials and methods for treatment of pain related disorders202311,787,486Motor stall and trailer lift202311,622,977Materials and methods for engineering cells and uses thereof in immuno-oncology202311,599,892Methods and systems to extract signals from large and imperfect datasets202311,593,886Methods and systems to quantify and index correlation risk in financial markets and risk management contracts thereon202311,587,172Methods and systems to quantify and index sentiment risk in financial markets and risk management contracts thereon202311,564,997Materials and methods for treatment of friedreich ataxia and other related disorders202311,559,588Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders202311,551,305Methods and systems to quantify and index liquidity risk in financial markets and risk management contracts thereon202311,471,491Materials and methods for engineering cells and uses thereof in immuno-oncology202211,459,587Materials and methods for treatment of pain related disorders202211,427,838Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders202211,407,997Materials and methods for treatment of primary hyperoxaluria type 1 (PH1) and other alanine-glyoxylate aminotransferase (AGXT) gene related conditions or disorders202211,298,378Materials and methods for engineering cells and uses thereof in immuno-oncology202211,207,351Materials and methods for engineering cells and uses thereof in immuno-oncology202111,202,802Materials and methods for engineering cells and uses thereof in immuno-oncology202111,191,783Materials and methods for engineering cells and uses thereof in immuno-oncology202111,174,469Materials and methods for treatment of Amyotrophic Lateral Sclerosis (ALS) and other related disorders202111,135,247Materials and methods for engineering cells and uses thereof in immuno-oncology2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to CRISPR THERAPEUTICS AG (12)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to VERTEX PHARMA (4)· patent assignee history
2023–2025Patents assigned to ECONOMIC ALCHEMY INC (7)· patent assignee history
2023–2025Patents assigned to OUTRIDER TECH INC (3)· patent assignee history
2023Patents assigned to ORACLE INT CORP (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CRISPR THERAPEUTICS AG | 12 | 2021–2024 |
| ECONOMIC ALCHEMY INC | 7 | 2023–2025 |
| VERTEX PHARMA | 4 | 2022–2025 |
| OUTRIDER TECH INC | 3 | 2023–2025 |
| ORACLE INT CORP | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 27 | 2021–2025 |